TuisGALE • SWX
add
Galenica AG
Vorige sluiting
CHF 75,85
Dagwisseling
CHF 75,90 - CHF 77,15
Jaarwisseling
CHF 69,30 - CHF 78,15
Markkapitalisasie
3,86 mjd CHF
Gemiddelde volume
58,42 k
P/V-verhouding
21,73
Dividend-opbrengs
2,85%
Primêre beurs
SWX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CHF) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 953,21 m | 2,53% |
Bedryfskoste | 71,97 m | -5,03% |
Netto inkomste | 39,44 m | -57,81% |
Netto winsgrens | 4,14 | -58,85% |
Wins per aandeel | — | — |
EBITDA | 63,49 m | 10,61% |
Effektiewe belastingkoers | 19,46% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CHF) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 69,55 m | 353,69% |
Totale bates | 3,01 mjd | 7,05% |
Totale aanspreeklikheid | 1,60 mjd | 7,96% |
Totale ekwiteit | 1,41 mjd | — |
Uitstaande aandele | 49,93 m | — |
Prys om te bespreek | 2,69 | — |
Opbrengs op bates | 4,17% | — |
Opbrengs op kapitaal | 5,56% | — |
Kontantvloei
Netto kontantverandering
| (CHF) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 39,44 m | -57,81% |
Kontant van bedrywe | 21,91 m | 781,26% |
Kontant van beleggings | -31,47 m | -3,71% |
Kontant van finansiering | -13,83 m | -21,14% |
Netto kontantverandering | -23,31 m | 40,69% |
Beskikbare kontantvloei | 37,56 m | -0,01% |
Meer oor
Galenica AG, headquartered in Bern, is an internationally active Swiss pharmaceutical and logistics company group, named after the ancient physician Galenus. It dates back to the 1927 Collaboration Pharmaceutique SA, a purchasing center for pharmaceutical products founded by 16 pharmacists in Clarens. This was renamed to Galenica AG in 1932 and moved from Vaud's Le Châtelard to Bern. The Galenica shares are listed on the SIX Swiss Exchange and are a component of the SMI MID index. Wikipedia
Gestig
1927
Webwerf
Werknemers
7 955
